BR9916919A - Compósito de sulfonamida e seu uso - Google Patents

Compósito de sulfonamida e seu uso

Info

Publication number
BR9916919A
BR9916919A BR9916919-3A BR9916919A BR9916919A BR 9916919 A BR9916919 A BR 9916919A BR 9916919 A BR9916919 A BR 9916919A BR 9916919 A BR9916919 A BR 9916919A
Authority
BR
Brazil
Prior art keywords
action
compound
sulfonamide
diseases based
composite
Prior art date
Application number
BR9916919-3A
Other languages
English (en)
Inventor
Hiroshi Kayakiri
Yoshito Abe
Hitoshi Hamashima
Hitoshi Sawada
Naoki Ishibashi
Hiroyuki Setol
Teruo Oku
Noritsugu Yamasaki
Takafumi Imoto
Takahiro Hiramura
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BR9916919A publication Critical patent/BR9916919A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSTO DE SULFONAMIDA E SEU USO". A presente invenção refere-se a um composto de sulfonamida da fórmula (I): onde cada símbolo é conforme definido na especificação, um sal do mesmo, e uma composição farmacêutica contendo o mesmo. Este composto pode ser um agente eficaz na profilaxia e tratamento das doenças curáveis com base numa ação hipoglicêmica, e das doenças curáveis com base numa ação inibidora de cGMP-PDE, ação relaxante sobre a musculatura lisa, ação broncodilatadora, ação vasodilatadora, ação inibidora de células da musculatura lisa e ação supressora de alergia.
BR9916919-3A 1998-12-04 1999-12-01 Compósito de sulfonamida e seu uso BR9916919A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP34617598 1998-12-04
JP36754098 1998-12-24
JP25928399 1999-08-09
PCT/JP1999/006748 WO2000034277A1 (fr) 1998-12-04 1999-12-01 Composes de sulfamide et utilisations de ces derniers en tant que medicaments

Publications (1)

Publication Number Publication Date
BR9916919A true BR9916919A (pt) 2002-01-15

Family

ID=27334802

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916919-3A BR9916919A (pt) 1998-12-04 1999-12-01 Compósito de sulfonamida e seu uso

Country Status (15)

Country Link
US (2) US6573274B1 (pt)
EP (1) EP1136492A4 (pt)
KR (1) KR20010086593A (pt)
CN (1) CN1335847A (pt)
AR (1) AR021542A1 (pt)
AU (1) AU769890B2 (pt)
BR (1) BR9916919A (pt)
CA (1) CA2352871A1 (pt)
CZ (1) CZ20011981A3 (pt)
HK (1) HK1044154A1 (pt)
HU (1) HUP0104549A3 (pt)
IL (1) IL143439A0 (pt)
TR (1) TR200101568T2 (pt)
TW (1) TW577889B (pt)
WO (1) WO2000034277A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348474B1 (en) * 1997-06-27 2002-02-19 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof
AU2001276607A1 (en) * 2000-08-11 2002-02-25 Pfizer Inc. Treatment of the insulin resistance syndrome with selective CGMP PDE5 inhibitors
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US20050197376A1 (en) * 2004-03-02 2005-09-08 Fujisawa Pharmaceutical Co. Ltd. Concomitant drugs
EP2114856A1 (en) * 2007-02-06 2009-11-11 Cipla Limited Process for the preparation of ethyl-n-(2, 3-dichloro-6-nitrobenzyl) glycine hydrochloride
WO2014123203A1 (ja) * 2013-02-06 2014-08-14 京都薬品工業株式会社 糖尿病治療薬
GB201321741D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
TWI731317B (zh) * 2013-12-10 2021-06-21 美商健臻公司 原肌球蛋白相關之激酶（ｔｒｋ）抑制劑
LT3762368T (lt) 2018-03-08 2022-06-10 Incyte Corporation Aminopirazindiolio junginiai, kaip pi3k-γ inhibitoriai
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215994A (en) 1990-09-25 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Angiotenin II antagonizing heterocyclic derivatives
EP0503838A3 (en) * 1991-03-08 1992-10-07 Merck & Co. Inc. Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
US5128327A (en) * 1991-03-25 1992-07-07 Merck & Co., Inc. Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
WO1993019067A1 (en) 1991-09-12 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine derivatives as angiotensin ii antagonists
IL124969A (en) 1995-12-28 2002-09-12 Fujisawa Pharmaceutical Co History of benzimidazole, processes for their preparation and pharmaceutical preparations containing them
EP1000932B9 (en) 1997-06-27 2005-12-28 Fujisawa Pharmaceutical Co., Ltd. Aromatic ring derivatives
US6348474B1 (en) * 1997-06-27 2002-02-19 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof

Also Published As

Publication number Publication date
HK1044154A1 (zh) 2002-10-11
WO2000034277A1 (fr) 2000-06-15
AU769890B2 (en) 2004-02-05
TR200101568T2 (tr) 2001-10-22
EP1136492A4 (en) 2002-03-27
HUP0104549A2 (hu) 2002-04-29
EP1136492A1 (en) 2001-09-26
AR021542A1 (es) 2002-07-24
CA2352871A1 (en) 2000-06-15
AU1414100A (en) 2000-06-26
US6573274B1 (en) 2003-06-03
IL143439A0 (en) 2002-04-21
TW577889B (en) 2004-03-01
CN1335847A (zh) 2002-02-13
US20030171396A1 (en) 2003-09-11
HUP0104549A3 (en) 2002-12-28
CZ20011981A3 (cs) 2002-01-16
US6890934B2 (en) 2005-05-10
KR20010086593A (ko) 2001-09-13

Similar Documents

Publication Publication Date Title
BRPI0405166A (pt) Composição de cuidados pessoais e processo para preparar a mesma
BR0111196A (pt) Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus
IT1252868B (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
BRPI0113042B8 (pt) composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
BR0312286A (pt) pró-medicamentos de 2' e 3' - nucleosìdeo modificado para tratamento de infecções por flaviviridae
BR0108173A (pt) Composições farmacêuticas de toxina de botulina
BR9916919A (pt) Compósito de sulfonamida e seu uso
BR9911076A (pt) Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
BRPI0517773A (pt) composição para cuidados pessoais contendo um derivado de polìmero de galactomanano não-guar
BRPI0412489A (pt) composição de confeito mastigável liberando para as superfìcies dentárias uma dose unitária de uma enzima
BR0316082A (pt) Métodos de tratar ou prevenir e de controlar uma doença mieloproliferative, de reduzir ou evitar um efeito adverso associado com a administração de um segundo agente ativo em um paciente sofrendo de uma doença mieloproliferativa e de aumentar a eficácia terapêutica de um tratamento de doenças mieloproliferativa, composição farmacêutica e kit
BR9702362A (pt) Novas fomrulações lìquidas estáveis à base de paracetamol e seu modo de preparação.
BR9917112A (pt) Compostos de imidazol e seu uso medicinal
SE0101387D0 (sv) Novel compounds
BR9914954A (pt) Implante com cavidades contendo agentes terapêuticos
BR0113087A (pt) Novas composições de minoxidil
BR0113643A (pt) Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos
BRPI0407950A (pt) processo para a preparação de uma composição de higiene pessoal
BR0111358A (pt) Compostos de tioacetamida e seu uso
BR0316310A (pt) Composições farmacêuticas tendo um veìculo modificado
EP0937453A3 (en) Cosmetic and tissue cleansing and moisturizing composition
BRPI0406796A (pt) Métodos para tratar hipertrofia prostática benigna, para reduzir um sintoma associado com a mesma, para reduzir o tamanho da próstata em um indivìduo humano e para profilaxia de bhp, composição farmacêutica oral de dose unitária, e, uso de lonidamina ou um análogo de lonidamina
EP1074245A3 (en) Composition using mineral salts for therapeutic treatment
BR9814214A (pt) Composição com ácido azeláico
BR0012444A (pt) Composições de pó seco

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.